GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
TD Cowen Maintains Avidity Biosciences(RNA.US) With Buy Rating, Announces Target Price $56
Contineum Therapeutics Announces Appointment of Sarah Boyce to Board of Directors
Have Insiders Sold Avidity Biosciences Shares Recently?
Avidity Biosciences(RNA.US) Director Sells US$187.95K in Common Stock
Express News | Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Avidity Biosciences Insider Sold Shares Worth $1,255,040, According to a Recent SEC Filing
(RNA) - Analyzing Avidity Biosciences's Short Interest
Estimating The Intrinsic Value Of Avidity Biosciences, Inc. (NASDAQ:RNA)
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
Avidity Biosciences(RNA.US) Officer Sells US$3.72 Million in Common Stock
Avidity Biosciences(RNA.US) Director Sells US$3.81 Million in Common Stock
Avidity Biosciences(RNA.US) Officer Sells US$11.59 Million in Common Stock
Avidity Biosciences to Participate in Upcoming Investor Conference
Wells Fargo Maintains Avidity Biosciences(RNA.US) With Buy Rating, Raises Target Price to $75
Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
Avidity Biosciences Raises $400M via Stock Offering